跳至主要内容
临床试验/NCT05324462
NCT05324462已完成不适用

Glycaemic Control and Other Clinical Parameters in Adult Type 2 Diabetes Patients on Basal Insulin Initiating Treatment With IDegLira in Routine Clinical Practice in Colombia - A Single-arm, Non-interventional Retrospective Chart Review Study

Novo Nordisk A/S1 个研究点 分布在 1 个国家目标入组 175 人开始时间: 2022年3月22日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
175
试验地点
1
主要终点
Change in local laboratory measured Glycated Haemoglobin A1c (HbA1c)

研究概览

简要总结

The purpose of this study is to investigate the glycaemic control and other clinical parameters in adult patients previously treated with basal insulin (with or without OADs) and switched to IDegLira in real-world clinical practice in Colombia.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

IDegLira

Adult patients with T2D who have initiated treatment with IDegLira a minimum of 26 weeks

干预措施: IDegLira (Drug)

结局指标

主要结局

Change in local laboratory measured Glycated Haemoglobin A1c (HbA1c)

时间窗: From baseline (week 0) to end of study (week 26 plus/minus 6 weeks) after IDegLira initiation

Percentage point

次要结局

  • Comparison between the daily dose of basal insulin and IDegLira(From baseline (week 0) to end of study (week 26 plus/minus 6 weeks) after IDegLira initiation)
  • Change in absolute body weight(From baseline (week 0) to end of study (week 26 plus/minus 6 weeks) after IDegLira initiation)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验